TY  - CHAP
M1  - Book, Section
TI  - Legal Aspects of Drug Information
A1  - Rumore, Martha M.
A2  - Malone, Patrick M.
A2  - Witt, Benjamin A.
A2  - Malone, Meghan J.
A2  - Peterson, David M.
PY  - 2022
T2  - Drug Information: A Guide for Pharmacists, 7e
AB  - Learning  ObjectivesAfter  completing  this  chapter,  the  reader  will  be  able  to:Describe  the  legal  issues  related  to  the  provision  of  drug  information  (DI).Apply  various  legal  theories  that  impose  liability  on  pharmacists  providing  DI.Describe  how  pharmacists  can  help  protect  themselves  from  malpractice  claims  resulting  from  the  provision  of  DI.Explain  the  Doctrine  of  Drug  Overpromotion  as  it  pertains  to  the  1997  Food  and  Drug  Administration  Modernization  Act  (FDAMA).Identify  the  liability  concerns  inherent  with  off-label  drug  use  and  informed  consent.Describe  U.S.  copyright  law  as  it  pertains  to  the  provision  of  DI.Identify  copyright,  liability,  and  privacy  issues  arising  from  the  Internet  and  Social  Media.Describe  the  legal  and  ethical  challenges  emerging  in  telemedicine  and  cybermedicine.Describe  the  DI  plan  that  addresses  the  Health  Insurance  Portability  and  Accountability  Act  (HIPAA)  of  1996.Explain  the  legal  issues  involved  with  industry  support  for  pharmaceutical  educational  activities.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1190460556
ER  -